focus -WSS

focus

author：explore 2025-09-29 16:45:58 - browse：71545

Jamy Ard (left) and Robert Lustig (right) on the 2023 STAT Breakthrough Summit stage -- coverage from STAT — Obesity experts Jamy Ard (left) and Robert Lustig speak at a panel during the 2023 STAT Breakthrough Summit. Sarah Gonzalez for STAT

Amid rising demand for drugs like Wegovy, Ozempic, and Mounjaro that can lead to significant weight loss, some obesity experts are concerned about the drugs’ costs — both to patients’ finances and to their health.

Speaking at a panel on new obesity treatments at the STAT Breakthrough Summit in San Francisco on Thursday, one expert cited a large clinical trial for Wegovy that showed that about 40% of the weight participants lost was lean mass. Side effects like nausea, vomiting, and a possible link to rare cases of pancreatitis also still plague this newest class of drugs, which imitate the effects of a hormone called glucagon-like peptide 1 (GLP) that helps people feel full.

“That’s what starvation does. You lose equal amounts of muscle and fat,” said Robert Lustig, emeritus professor of pediatrics at the University of California, San Francisco. “If you’re a person 60 years old or over and you’re losing muscle, your risk of dying just went up exponentially. So we may be … robbing Peter to pay Paul.”

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： At least 13 dead in Texas as scorching temps continue
Next article： Organ aging and disease risk measured by new blood test

WSS

What health policies could hitch a ride on a spending bill?

What don’t we know about an Alzheimer’s drug side effect?

Organ aging and disease risk measured by new blood test

U.K. Biobank has 500,000 peoples' genome sequences available

UnitedHealth sued over use of algorithm in Medicare Advantage plans

Mayo Clinic plans $5B tech

hotspot

focus

hotspot

In age of alternative facts, a scholarly course on calling out crap

Readout Newsletter: Zepbound, Valneva's vaccine, and more

How one medical school became remarkably diverse

Takeda, Janssen join wearable maker to measure scratching

Malaria cases in Florida and Texas: Here’s what you need to know

UnitedHealth’s Optum accused of antitrust violations in California

Over 800 arrested across France in 3rd night of riots after fatal police shooting of teen

UnitedHealth sued over use of algorithm in Medicare Advantage plans

New Eli Lilly Alzheimer’s data poses Medicare coverage conundrum

Eli Lilly’s chief scientist on obesity drugs, gene editing, and more

explore

Readout Newsletter: Zepbound, Valneva's vaccine, and more

How to pay for weight loss drugs and save Medicare

Today's health inequities arise from racist U.S. history, say experts

BIO selects John Crowley as new CEO

With clinical trial data readouts, here's how to spot spin

Healthy food access boosts outcomes in two studies

focus

explore

knowledge

knowledge